OCUL

OCUL

USD

Ocular Therapeutix Inc. Common Stock

$10.900-0.300 (-2.679%)

Echtzeitkurs

Healthcare
Biotechnologie
Vereinigte Staaten

Kursdiagramm

Loading Chart...

Schlüsselkennzahlen

Marktkennzahlen
Unternehmensfundamentaldaten
Handelsstatistiken

Marktkennzahlen

Eröffnung

$11.200

Hoch

$11.355

Tief

$10.400

Volumen

1.84M

Unternehmensfundamentaldaten

Marktkapitalisierung

2.3B

Branche

Biotechnologie

Land

United States

Handelsstatistiken

Durchschnittliches Volumen

2.72M

Börse

NGM

Währung

USD

52-Wochen-Spanne

Tief $5.785Aktuell $10.900Hoch $13.85

Ähnliche Nachrichten

GlobeNewswire

Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlights

Recent Investor Day highlighted how AXPAXLI™ is positioned to redefine retina based on potential superiority label, market expansion, and immediate adoptability Announced today that SOL-R achieved target

Mehr anzeigen
Ocular Therapeutix™ Reports Third Quarter 2025 Financial Results and Business Highlights
Analyst Upgrades

TD Cowen Maintains Buy on Ocular Therapeutix, Raises Price Target to $20

TD Cowen analyst Tara Bancroft maintains Ocular Therapeutix with a Buy and raises the price target from $14 to $20.

Mehr anzeigen
TD Cowen Maintains Buy on Ocular Therapeutix, Raises Price Target to $20
GlobeNewswire

Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025

BEDFORD, Mass., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ:OCUL, "Ocular")), an integrated biopharmaceutical company committed to redefining the retina experience, today announced that it plans

Mehr anzeigen
Ocular Therapeutix™ to Report Third Quarter 2025 Financial Results on November 4, 2025

Bleiben Sie auf dem Laufenden

Preisalarme setzen, KI-Analyse-Updates und Echtzeit-Marktnachrichten erhalten.